Skip to content

PHARMASSISTANCE

Active Public limited companyfounded 1993active for 33 yearsDoornboomstraat 5, 2440 GeelKBO/BCE: BE 0449.618.655

Lifetime

20 annual accounts with figures on one time axis, 32 filings since 1994
peak of €31,580 in 2017
€11,393▲ 68.0%
lowest -€23,783 in 2011
-€1,501▲ €5,302
peak of -€292,582 in 2006
-€368,433▼ €1,501
€397,327▲ 2.0%
Board3 names since 1993
2 directors and 1 other
Documentsfilings and deeds
17-06-202644 days before the deadline
2025micro format
Gross margin from €6,782 to €11,393Loss of €1,501Cash from €670 to €1,177

Key points

from the 2025 annual accounts

Equity

-€368,433
202020212022202320242025

Debts exceed assets in financial year 2025.

Losses

-€17,748 in four years
-7,1772022-2,2672023-6,8032024-1,5012025

Every financial year from 2022 to 2025 closed with a loss. 2022 was the heaviest.

Turnover

≈ €51,000 estimated

The micro format states no turnover.

Debts

€397,327 1,375% of the balance sheet
Financial debts 14%Suppliers 1%Other 85%

Of this, €342,356 falls due within a year.

Filings

32 annual accounts since 1994
AprilJune31 JulyOctober200020102020

Six of the last ten came late. The 2019 accounts came in latest, 146 days after the end of the period.

Position in the sector

-1275.2%

Lower solvency than 95% of companies in head offices and management consultancy. The sector median is 55.5%, over 41,316 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 2,796 companies had the same profile as PHARMASSISTANCE has now. Each dot stands for 7 companies, two years later.

90.3%
were still trading
6.1%
stopped another way
2.1%
went bankrupt
  • Micro
  • 20 years or older
  • negative equity
  • a small loss

Another 1.5% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 2,796 companies, not a prediction for PHARMASSISTANCE. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Managing director,
Director
Director
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0449618655
1 director resigning, 2 reappointments changes role from director to managing director · resigns · (director) and (director) reappointed · Gazette deed
3 directors appointed, 1 resignation , and appointed · acts as permanent representative · resigns · General meeting of 01-09-2020 · Gazette deed
Registered office moved within Geel The registered office moved from Steleseweg 62, 2440 Geel to Doornboomstraat 5A, 2440 Geel · General meeting of 07-07-2016 · Gazette deed
All 43 events

Comparable companies

same main activity, similar in size and age
Company
PHARMASSISTANCE Geel €28,893 €11,393 -1275.2% -
TECHNICAL TRAINING AGENCY Geel €31,243 €14,172 51.6% 1
SOGESCAP Anhée €29,714 €11,557 39.4% -
35BIS Leuven €27,760 €12,901 49.2% -
International Business Intelligence Services Villers-la-Ville €29,081 €10,809 36.5% -
Performance Habitat Ham-sur-Heure-Nalinnes €28,958 €11,030 -112.8% -
BMC Overijse €35,578 €10,911 57.7% -

These companies have the same main activity as PHARMASSISTANCE: business and other management consultancy (NACE 70200). They are comparable in size and age: total assets between €27,800 and €35,600, founded between 1990 and 1998.

Official details

Source: KBO
Status
Active since 10-03-1993Normal situation
Activity
Business and other management consultancyNACE 70200
Establishment unit
2.102.886.9522440 Geel, since 24-03-1993
Financial year end
31 December
Peppol
Reachable since 26-09-2025
Company details

Annual accounts 2025

€28,893▲ 28.1%
Filing
Filed on 17-06-2026, 44 days before the end of the filing period
Financials

Insights on PHARMASSISTANCE

PHARMASSISTANCE files the micro format. That format states no turnover. The gross margin rose from -€7,584 in 2006 to €11,393 in 2025.

In December 2023, the Official Gazette published the appointment of as managing director.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about PHARMASSISTANCE

What is the company number of PHARMASSISTANCE?
The company number of PHARMASSISTANCE is 0449.618.655. The VAT number is the same number with BE in front: BE 0449.618.655.
Where is PHARMASSISTANCE based?
The registered office is at Doornboomstraat 5, 2440 Geel.Company details
What does PHARMASSISTANCE do?
According to the KBO register, the main activity is business and other management consultancy (NACE 70200).
What is the legal form of PHARMASSISTANCE?
PHARMASSISTANCE is a public limited company (NV).
When was PHARMASSISTANCE founded?
PHARMASSISTANCE was founded on 10-03-1993.
Is PHARMASSISTANCE still active?
Yes, PHARMASSISTANCE is an active enterprise in the KBO register.
What is the turnover of PHARMASSISTANCE?
The turnover in financial year 2025 is about €51,000. This figure is estimated from the gross margin of €11,393 and 257 comparable companies (NACE 70200). It probably lies between €23,000 and €100,000. It is a rough estimate.Financials
Is PHARMASSISTANCE profitable?
In financial year 2025, PHARMASSISTANCE made a loss of €1,501.
Where can I find the annual accounts of PHARMASSISTANCE?
PHARMASSISTANCE filed 32 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of PHARMASSISTANCE due?
PHARMASSISTANCE must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.